Epidermal Growth Factor (EGF) in the Human Placental Infection with Trypanosoma cruzi

• Published in: Placenta (Eastbourne) Vol. 25; no. 4; pp. 283 - 286
• Main Authors: Lin, S, Sartori, M.J, Mezzano, L, de Fabro, S.P
• Format: Journal Article
• Language: English
• Published: Oxford Elsevier Ltd 01.04.2004; Elsevier
• Subjects: Adult; Animals; Biological and medical sciences; Cells, Cultured; Chagas Disease - blood; Chorionic Villi - metabolism; Chorionic Villi - parasitology; Chorionic Villi - pathology; Epidermal Growth Factor - blood; Female; Gestational Age; Human protozoal diseases; Humans; Image Processing, Computer-Assisted; Immunoenzyme Techniques; Infectious diseases; Medical sciences; Parasitic diseases; Placenta - metabolism; Placenta - parasitology; Pregnancy - blood; Pregnancy Complications, Parasitic - blood; Protozoal diseases; Receptor, Epidermal Growth Factor - metabolism; Toxoplasmosis; Trypanosoma cruzi - isolation & purification; Human; Infection; Protozoal disease; Epidermal growth factor; Placenta; Fetal membrane; Chagas disease; Parasitosis; Placenta diseases; Trypanosomiasis

Maternal infection of Trypanosoma cruzi is associated with premature births, abortions and placentitis. A decrease in EGF levels has been suggested to occur in animals infected by T. cruzi, but there is no research about the levels of EGF in human patients with Chagas' disease. We evaluated ser...